Comments
Loading...
Ironwood Pharmaceuticals Insider Trading Activity | NASDAQ:IRWD | Benzinga
Track the latest Ironwood Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for Ironwood Pharmaceuticals stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Ironwood Pharmaceuticals Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On February 12, 2025, Ronald Silver, the company's PRINCIPAL ACCOUNTING OFFICER sold 12.05K shares for $1.76 each.
- On February 12, 2025, Gregory Martini, the company's CHIEF FINANCIAL OFFICER sold 12.05K shares for $1.76 each.
- On February 12, 2025, Thomas MCCOURT, the company's CHIEF EXECUTIVE OFFICER sold 139.06K shares for $1.76 each.
Ownership Statistics for Ironwood Pharmaceuticals Inc
Shares Outstanding
161.820M
Insider Shares Owned
10.977M
Insider Percentage Owned
6.78%
Institutional Shares Held
49.798M
Institutional Percentage Held
30.8%
| Feb 12, 2025 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | -139.06K | $1.76 | -$244.75K | SELL | -10.70% | 1.16M | Feb 10 | View |
| Feb 12, 2025 | Ronald Silver | PRINCIPAL ACCOUNTING OFFICER | -12.05K | $1.76 | -$21.20K | SELL | -4.13% | 279.65K | Feb 10 | View |
| Feb 12, 2025 | Michael Shetzline | SVP, CMO, HEAD-RES&DRUG | 92.06K | $1.76 | -$72.63K | GRANT | 19.93% | 554.01K | Feb 10 | View |
| Feb 12, 2025 | Minardo John | CHIEF LEGAL OFFICER | 83.28K | $1.76 | -$68.53K | GRANT | 25.64% | 408.13K | Feb 10 | View |
| Feb 12, 2025 | Gregory Martini | CHIEF FINANCIAL OFFICER | -12.05K | $1.76 | -$21.21K | SELL | -6.15% | 183.81K | Feb 10 | View |
| Nov 20, 2024 | Andrew Davis | SVP, CHIEF BUSINESS OFFICER | -5.36K | $4.08 | -$21.87K | SELL | -1.85% | 284.69K | Nov 18 | View |
| Nov 20, 2024 | Kumar Sravan Emany | SVP, COO AND CFO | -11.00K | $4.08 | -$44.88K | SELL | -3.43% | 309.57K | Nov 18 | View |
| Aug 14, 2024 | Minardo John | CHIEF LEGAL OFFICER | -9.91K | $4.27 | -$42.32K | SELL | -3.36% | 284.66K | Aug 12 | View |
| Aug 14, 2024 | Ronald Silver | PRINCIPAL ACCOUNTING OFFICER | -3.11K | $4.27 | -$13.27K | SELL | -1.92% | 158.37K | Aug 12 | View |
| Jun 12, 2024 | Julie McHugh | — | -22.77K | $6.29 | -$143.20K | SELL | -14.03% | 139.53K | Jun 10 | View |
| Jun 10, 2024 | Catherine Moukheibir | — | -80.00K | $6.47 | -$517.69K | SELL | -62.19% | 48.63K | Jun 06 - Jun 07 | View |
| May 22, 2024 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | -67.62K | $6.45 | -$436.14K | SELL | -5.55% | 1.15M | May 20 | View |
| May 22, 2024 | Andrew Davis | SVP, CHIEF BUSINESS OFFICER | -22.73K | $6.45 | -$146.58K | SELL | -7.31% | 288.03K | May 20 | View |
| May 22, 2024 | Michael Shetzline | CMO,SVP,HEAD-RES&DRUG | -16.13K | $6.45 | -$104.03K | SELL | -3.75% | 413.72K | May 20 | View |
| May 22, 2024 | Minardo John | CHIEF LEGAL OFFICER | -17.40K | $6.45 | -$112.26K | SELL | -5.58% | 294.57K | May 20 | View |
| Mar 08, 2024 | Jon Duane | — | 6.92K | $8.70 | $60.20K | BUY | 6.06% | 121.03K | Mar 06 | View |
| Mar 06, 2024 | Kumar Sravan Emany | SVP, CHIEF FINANCIAL OFFICER | 10.68K | $9.38 | $100.22K | BUY | 3.67% | 301.73K | Mar 04 | View |
| Feb 14, 2024 | Minardo John | CHIEF LEGAL OFFICER | 7.05K | $15.24 | -$722.07K | GRANT | 2.59% | 279.22K | Feb 12 | View |
| Feb 14, 2024 | Michael Shetzline | CMO,SVP,HEAD-RES&DRUG | 15.81K | $15.24 | -$588.54K | GRANT | 4.17% | 394.91K | Feb 12 | View |
| Feb 14, 2024 | Ronald Silver | PRINCIPAL ACCOUNTING OFFICER | 19.30K | $15.24 | -$120.52K | GRANT | 13.58% | 161.48K | Feb 12 | View |
| Feb 14, 2024 | Andrew Davis | SVP, CHIEF BUSINESS OFFICER | 55.47K | $15.24 | -$150.05K | GRANT | 25.42% | 273.64K | Feb 12 | View |
| Feb 14, 2024 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | -177.16K | $15.24 | -$2.70M | SELL | -17.54% | 832.77K | Feb 12 | View |
| Dec 18, 2023 | Marla Kessler | DIRECTOR | -9.93K | $11.19 | -$111.07K | SELL | -9.32% | 96.57K | Dec 14 | View |
| Nov 22, 2023 | Andrew Davis | SVP, CHIEF BUSINESS OFFICER | -3.29K | $9.69 | -$31.85K | SELL | -1.49% | 217.37K | Nov 20 | View |
| Sep 18, 2023 | Kumar Sravan Emany | SVP, CHIEF FINANCIAL OFFICER | 36.07K | $8.32 | $300.12K | BUY | 23.63% | 188.73K | Sep 15 | View |
| Aug 16, 2023 | Ronald Silver | PRINCIPAL ACCOUNTING OFFICER | -1.98K | $10.04 | -$19.84K | SELL | -1.45% | 134.17K | Aug 14 | View |
| Aug 16, 2023 | Minardo John | CHIEF LEGAL OFFICER | -7.04K | $10.04 | -$70.73K | SELL | -3.54% | 192.19K | Aug 14 | View |
| Jun 01, 2023 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | -26.63K | $10.70 | -$284.96K | SELL | -3.39% | 758.28K | May 30 | View |
| May 24, 2023 | Michael Shetzline | CMO,SVP,HEAD-RES&DRUG | -10.32K | $10.12 | -$104.48K | SELL | -3.11% | 321.13K | May 22 | View |
| May 24, 2023 | Andrew Davis | SVP, CHIEF BUSINESS OFFICER | -6.30K | $10.12 | -$63.81K | SELL | -2.79% | 219.33K | May 22 | View |
| May 24, 2023 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | -36.00K | $10.12 | -$364.32K | SELL | -4.39% | 784.92K | May 22 | View |
| May 10, 2023 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | -21.15K | $10.62 | -$224.59K | SELL | -2.51% | 820.92K | May 08 | View |
| Mar 29, 2023 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | -46.13K | $10.67 | -$492.20K | SELL | -5.19% | 842.06K | Mar 27 | View |
| Mar 07, 2023 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | -33.76K | $11.22 | -$378.74K | SELL | -4.95% | 647.60K | Mar 03 | View |
| Mar 01, 2023 | Ronald Silver | PRINCIPAL ACCOUNTING OFFICER | -5.98K | $11.36 | -$67.90K | SELL | -5.72% | 98.49K | Feb 27 - Feb 28 | View |
| Mar 01, 2023 | Jason Rickard | SVP, CHIEF OPERATING OFFICER | -34.17K | $11.36 | -$388.19K | SELL | -9.32% | 332.65K | Feb 27 - Feb 28 | View |
| Mar 01, 2023 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | -61.23K | $11.36 | -$695.52K | SELL | -8.25% | 681.35K | Feb 27 - Feb 28 | View |
| Mar 01, 2023 | Michael Shetzline | CMO,SVP,HEAD-RES&DRUG | -19.32K | $11.36 | -$219.48K | SELL | -6.88% | 261.59K | Feb 27 - Feb 28 | View |
| Mar 01, 2023 | Minardo John | CHIEF LEGAL OFFICER | -6.70K | $11.36 | -$76.07K | SELL | -4.77% | 133.74K | Feb 27 - Feb 28 | View |
| Mar 01, 2023 | Andrew Davis | SVP, CHIEF BUSINESS OFFICER | -3.57K | $11.36 | -$40.59K | SELL | -2.31% | 151.40K | Feb 27 - Feb 28 | View |
| Jan 09, 2023 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | 0.00 | $11.86 | -$46.60K | SELL-OPTIONS | 0.00% | 712.44K | Jan 05 | View |
| Dec 16, 2022 | Jason Rickard | SVP, CHIEF OPERATING OFFICER | -27.00K | $12.39 | -$334.53K | SELL | -7.19% | 348.74K | Dec 14 | View |
| Nov 23, 2022 | Kumar Sravan Emany | SVP, CHIEF FINANCIAL OFFICER | -6.58K | $11.56 | -$76.04K | SELL | -7.74% | 78.42K | Nov 21 | View |
| Nov 23, 2022 | Ronald Silver | PRINCIPAL ACCOUNTING OFFICER | -682.00 | $11.56 | -$7.88K | SELL | -0.65% | 104.47K | Nov 21 | View |
| Nov 23, 2022 | Andrew Davis | SVP, CHIEF BUSINESS OFFICER | -3.33K | $11.56 | -$38.55K | SELL | -2.12% | 154.21K | Nov 21 | View |
| Oct 05, 2022 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | -18.90K | $10.41 | -$196.74K | SELL | -2.58% | 712.44K | Oct 03 | View |
| Sep 06, 2022 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | -26.45K | $10.65 | -$281.65K | SELL | -3.49% | 731.34K | Sep 01 | View |
| Aug 17, 2022 | Ronald Silver | PRINCIPAL ACCOUNTING OFFICER | -2.01K | $11.77 | -$23.70K | SELL | -1.88% | 105.15K | Aug 15 | View |
| Aug 17, 2022 | Jason Rickard | SVP, CHIEF OPERATING OFFICER | -994.00 | $11.77 | -$11.70K | SELL | -0.26% | 375.74K | Aug 15 | View |
| Aug 17, 2022 | Minardo John | CHIEF LEGAL OFFICER | -7.33K | $11.77 | -$86.27K | SELL | -4.96% | 140.44K | Aug 15 | View |
| Aug 15, 2022 | Mark Currie | DIRECTOR | -70.00K | $11.78 | -$824.60K | SELL | -11.83% | 521.76K | Aug 11 | View |
| Aug 10, 2022 | Jason Rickard | SVP, CHIEF OPERATING OFFICER | -29.44K | $11.66 | -$344.26K | SELL | -7.25% | 376.73K | Aug 08 - Aug 09 | View |
| Aug 03, 2022 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | -23.23K | $11.35 | -$263.65K | SELL | -2.97% | 757.78K | Aug 01 | View |
| Jul 05, 2022 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | -19.96K | $11.58 | -$231.13K | SELL | -2.50% | 778.92K | Jun 30 | View |
| Jun 16, 2022 | Marla Kessler | DIRECTOR | -7.61K | $11.65 | -$88.66K | SELL | -8.29% | 84.15K | Jun 14 | View |
| Jun 09, 2022 | Mark Currie | DIRECTOR | 0.00 | $11.83 | -$68.54K | SELL-OPTIONS | 0.00% | 591.76K | Jun 07 | View |
| May 25, 2022 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | -36.31K | $11.50 | -$417.54K | SELL | -4.35% | 798.88K | May 23 | View |
| May 25, 2022 | Ronald Silver | PRINCIPAL ACCOUNTING OFFICER | -120.00 | $11.50 | -$1.38K | SELL | -0.11% | 105.07K | May 23 | View |
| May 25, 2022 | Michael Shetzline | CMO,SVP,HEAD-RES&DRUG | -10.58K | $11.50 | -$121.70K | SELL | -3.82% | 266.25K | May 23 | View |
| May 25, 2022 | Jason Rickard | SVP, CHIEF OPERATING OFFICER | -13.54K | $11.50 | -$155.68K | SELL | -3.24% | 404.07K | May 23 | View |
| Mar 25, 2022 | Ronald Silver | PRINCIPAL ACCOUNTING OFFICER | -3.03K | $12.75 | -$38.65K | SELL | -2.80% | 105.19K | Mar 24 | View |
| Mar 16, 2022 | Julie McHugh | DIRECTOR | -20.00K | $11.67 | -$233.40K | SELL | -14.45% | 118.37K | Mar 14 | View |
| Mar 02, 2022 | Ronald Silver | PRINCIPAL ACCOUNTING OFFICER | -2.24K | $10.77 | -$24.10K | SELL | -3.53% | 61.21K | Feb 28 | View |
| Mar 02, 2022 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | -48.42K | $10.77 | -$521.53K | SELL | -7.63% | 586.32K | Feb 28 | View |
| Mar 02, 2022 | Michael Shetzline | CMO,SVP,HEAD-RES&DRUG | -17.61K | $10.77 | -$189.63K | SELL | -8.27% | 195.38K | Feb 28 | View |
| Mar 02, 2022 | Jason Rickard | SVP, CHIEF OPERATING OFFICER | -28.96K | $10.77 | -$311.92K | SELL | -8.13% | 327.11K | Feb 28 | View |
| Dec 23, 2021 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | -46.33K | $11.41 | -$528.59K | SELL | -7.46% | 574.45K | Dec 22 | View |
| Dec 20, 2021 | Jason Rickard | SVP, CHIEF OPERATING OFFICER | -27.00K | $11.28 | -$304.56K | SELL | -7.78% | 319.90K | Dec 16 | View |
| Dec 16, 2021 | Julie McHugh | DIRECTOR | -10.00K | $11.02 | -$110.20K | SELL | -6.74% | 138.37K | Dec 14 | View |
| Nov 24, 2021 | Thomas MCCOURT | CHIEF EXECUTIVE OFFICER | -52.64K | $11.58 | -$609.62K | SELL | -7.84% | 618.54K | Nov 23 | View |
| Nov 24, 2021 | Jason Rickard | SVP, CHIEF OPERATING OFFICER | -17.19K | $11.58 | -$199.09K | SELL | -4.75% | 344.67K | Nov 23 | View |
| Nov 24, 2021 | Michael Shetzline | CMO,SVP,HEAD-RES&DRUG | -13.78K | $11.58 | -$159.53K | SELL | -6.98% | 183.66K | Nov 23 | View |
| Nov 24, 2021 | Ronald Silver | PRINCIPAL ACCOUNTING OFFICER | -1.46K | $11.58 | -$16.93K | SELL | -2.33% | 61.21K | Nov 23 | View |
| Aug 18, 2021 | Ronald Silver | PRINCIPAL ACCOUNTING OFFICER | -567.00 | $13.48 | -$7.64K | SELL | -0.90% | 62.67K | Aug 16 | View |
| Aug 18, 2021 | Jason Rickard | SVP, CHIEF OPERATING OFFICER | -680.00 | $13.48 | -$9.17K | SELL | -0.19% | 361.86K | Aug 16 | View |
| Jun 16, 2021 | Mark Currie | DIRECTOR | -23.57K | $11.59 | -$273.19K | SELL | -3.97% | 570.19K | Jun 14 | View |
| May 26, 2021 | Michael Shetzline | CMO, SVP & HEAD DRUG DEVT. | -2.08K | $12.25 | -$25.44K | SELL | -1.04% | 197.44K | May 24 | View |
| May 26, 2021 | Jason Rickard | SVP, CHIEF OPERATING OFFICER | -516.00 | $12.25 | -$6.32K | SELL | -0.14% | 362.54K | May 24 | View |
| May 26, 2021 | Thomas MCCOURT | PRESIDENT AND INTERIM CEO | -1.72K | $12.25 | -$21.02K | SELL | -0.30% | 566.50K | May 24 | View |
| Mar 10, 2021 | ALEXANDER DENNERSarissa Capital Management LP | DIRECTOR | 225.00K | $10.38 | $2.34M | BUY | 1.39% | 16.43M | Mar 08 - Mar 10 | View |
| Mar 05, 2021 | ALEXANDER DENNERSarissa Capital Management LP | DIRECTOR | 775.00K | $10.01 | $7.76M | BUY | 5.02% | 16.20M | Mar 03 - Mar 05 | View |
| Mar 02, 2021 | Alexander Denner | DIRECTOR | 1.35M | $9.44 | $12.74M | BUY | 9.59% | 15.43M | Feb 26 - Mar 02 | View |
| Mar 02, 2021 | Michael Shetzline | CMO, SVP & HEAD DRUG DEVT. | -4.44K | $9.11 | -$40.44K | SELL | -2.69% | 160.86K | Feb 26 | View |
| Mar 02, 2021 | Jason Rickard | SVP, CHIEF OPERATING OFFICER | -13.65K | $9.11 | -$124.36K | SELL | -4.26% | 306.68K | Feb 26 | View |
| Mar 02, 2021 | Edward Owens | DIRECTOR | 3.00K | $8.90 | $26.70K | BUY | 1.17% | 258.95K | Feb 26 | View |
| Mar 02, 2021 | Thomas MCCOURT | PRESIDENT | -14.69K | $9.11 | -$133.78K | SELL | -3.02% | 471.58K | Feb 26 | View |
| Mar 02, 2021 | Mark Mallon | CHIEF EXECUTIVE OFFICER | -30.68K | $9.11 | -$279.45K | SELL | -6.12% | 470.61K | Feb 26 | View |
| Mar 02, 2021 | Conor Kilroy | SVP, GC & SECRETARY | -6.99K | $9.11 | -$63.67K | SELL | -5.40% | 122.34K | Feb 26 | View |
| Mar 02, 2021 | Gina Consylman | SVP, CFO & TREASURER | -18.41K | $9.11 | -$167.68K | SELL | -5.19% | 336.24K | Feb 26 | View |
| Feb 26, 2021 | Edward Owens | DIRECTOR | 12.00K | $9.20 | $110.37K | BUY | 4.92% | 255.95K | Feb 24 - Feb 25 | View |
| Dec 08, 2020 | Kelly MacDonald | — | 0.00 | $10.81 | -$19.06K | OPTION EXERCISE | 0.00% | 93.04K | Dec 04 | View |
| Nov 13, 2020 | Kelly MacDonald | — | 0.00 | $10.53 | -$8.69K | OPTION EXERCISE | 0.00% | 93.04K | Nov 11 | View |
| Nov 10, 2020 | Jason Rickard | — | -394.00 | $10.92 | -$4.30K | SELL | -0.17% | 235.38K | Nov 09 | View |
| Nov 10, 2020 | Kelly MacDonald | — | -2.80K | $11.14 | -$31.16K | SELL | -2.92% | 93.04K | Nov 06 - Nov 09 | View |
| Nov 10, 2020 | Conor Kilroy | — | -836.00 | $10.92 | -$9.13K | SELL | -0.64% | 128.83K | Nov 09 | View |
| Nov 10, 2020 | Gina Consylman | — | -1.42K | $10.92 | -$15.45K | SELL | -0.52% | 269.70K | Nov 09 | View |
| Oct 13, 2020 | Kelly MacDonald | — | -22.71K | $10.50 | -$238.50K | SELL | -19.16% | 95.84K | Oct 08 | View |
| Sep 09, 2020 | Julie McHugh | — | -7.95K | $9.77 | -$77.67K | SELL | -6.07% | 123.11K | Sep 08 | View |
| Aug 19, 2020 | Jason Rickard | — | -689.00 | $10.14 | -$6.99K | SELL | -0.29% | 235.78K | Aug 17 | View |
| Aug 19, 2020 | Kelly MacDonald | — | -575.00 | $10.14 | -$5.83K | SELL | -0.48% | 118.55K | Aug 17 | View |
| Jun 12, 2020 | LAWRENCE OLANOFF | — | -11.35K | $10.06 | -$114.18K | SELL | -14.19% | 68.63K | Jun 10 | View |
| May 13, 2020 | Jason Rickard | — | -510.00 | $10.35 | -$5.28K | SELL | -0.22% | 234.58K | May 11 | View |
| May 13, 2020 | Thomas MCCOURT | — | -1.70K | $10.35 | -$17.56K | SELL | -0.53% | 319.85K | May 11 | View |
| May 13, 2020 | Mark Mallon | — | -23.21K | $10.35 | -$240.18K | SELL | -4.42% | 501.28K | May 11 | View |
| May 13, 2020 | Kelly MacDonald | — | -1.15K | $10.35 | -$11.93K | SELL | -0.97% | 118.15K | May 11 | View |
| May 13, 2020 | Conor Kilroy | — | -716.00 | $10.35 | -$7.41K | SELL | -0.55% | 128.92K | May 11 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
